Good afternoon, and welcome to Ahlstrom's Second Quarter 2026 EarningsC all. My name is David Brilleslijper, Ahlstrom's Head of Investor Relations, and joining me today are Ahlstrom's President and CEO, Helen Mets, and our CFO, Niklas Beyes. Following the presentation, we will open the line for Q&A. You can submit your questions either online or by phone. I will now hand over to Helen Mets to begin the presentation. Helen, the floor is yours. Thank you, David, good morning, good afternoon, and potentially good evening, everyone. Welcome to the Q2 2026 results call. Looking forward to actually walk you through where we landed Q2. Let me start with a headline, which is accelerated performance in the quarter. This accelerated performance was driven by two things. One was momentum in our top line, so sales growth, combined with the execution of our strategic improvement initiatives. Net sales were actually up 6% in the quarter, landing at EUR 786 million. Again, just the background to that, we saw strong commercial momentum, which was supported in some ways by the market, but also by the execution of our innovation-led opportunity pipeline and the acquisition of Stevens Point. If you remember, we bought in Stevens Point at the end of May last year. Comparable EBITDA was up 16% at EUR 142 million. Actually, we saw all core divisions delivering accelerated performance, which was really great to see. Again, I think we said it the last time, I'll say it again, successful integration of our acquisition of Stevens Point and EBF. Our EBITDA margin improved to 18.1%. When we actually look at the three core divisions of Filtration & Life Sciences, our Food & Consumer Packaging, and Protective Materials, we actually got over the 20%. We ended at 20.6% EBITDA margins. True specialty materials margins. Our Margin On Variable Cost per ton was EUR 1,145, which is the highest MOVC that we've actually shown in the business. Again, going back to our MOVC per ton, it's driven by our pricing muscle, it's driven by our procurement and operational excellence, and our ongoing focus on the mix shift towards the specialty materials. We'll go into a little bit more detail with Niklas on the development there. We delivered solid operating cash flow in the quarter, and we successfully refinanced the U.S. dollar term loan. The good news there, it means that we've extended the maturity now of 80% of the financial debt structure of Ahlstrom to 2030. That certainly feels good. What actually drives the performance? If we can go to the next slide. You've seen this now a couple of times, but it's really our focus strategy, which is our three pillars. The first pillar being really choosing where we play. It's that strong portfolio management, choosing the markets and the segments where we just know that we are differentiated with our technology and where the products are actually mission-critical. Once we've chosen where to play, we've got two pillars. One is laser focus on building and closing our opportunity pipeline of growth, the second pillar is making sure that we drive safe and efficient operational excellence to actually make those products and that innovation. This quarter, we saw an acceleration of growth from that innovation-led opportunity pipeline in that second pillar. I wanted to take the opportunity actually to have a look at our innovation platforms, because I think, as you all know, innovation is the critical enabler of Ahlstrom's organic growth. You know it's a key driver for us, of course, in the long term, but also in the short term, and that's what we're demonstrating. Actually, if we look at the three platforms that we've got, what we see when we look at specialty materials, we've got a couple of big drivers that are driving increased demand. It's the requirement of safer chemicals, of circular solutions, and sustainable alternatives to things like single-use plastics. We've got three platforms that are designed around capturing those opportunities at scale. We've concentrated our resources behind them. We've got high growth conviction. We've got differentiated IP. As you can see, we're actually accelerating commercialization across the company. Let's just take a very quick look at the three. The first is our Boundless Barrier platform, here we're focused on expanding application area for our cellulose-based technology, particularly in food packaging, by developing what we call advanced barrier materials. This allows us to actually replace things like plastics, things like foils that are in demanding applications. Think about QSR, quick service restaurant applications or pet food packaging, where there's a requirement for grease-proof resistance, but also printability. Its performance is key. This is where our Boundless Barrier platform actually elevates growth. The second is our Safe Repellency platform, here we're developing fluoro-free and silicone-free technologies. Actually, we're taking really a front-leading position, despite regulations, in actually making sure that our portfolio is Safe and Sustainable by Design. The third platform, our Transparency platform, I think I've talked a couple of times about some of these applications. This is really taking what is already a leadership position in transparent fiber-based materials, and we're developing solutions here where we can actually dial up and down the transparency of paper, and we're really getting to very new and different boundaries on transparency. This is actually allowing us to get into different segments within certain applications, like for instance, bread, when we're looking at transparent windows, but also into smart packaging. Today we see a pathway to EUR 150 million of incremental revenue coming out of these platforms. They support our roadmap to getting 80% of our portfolio totally Safe and Sustainable by Design by 2030. In Q2 alone, we launched 25 new products that support and drive our top-line growth. As always, let me wrap up this section with a couple of the examples of actually what we've launched and announced in Q2. Maybe I'll start with the clean air and clean water in the middle of the page, because this is from our Safe Repellency platform. In the quarter, we expanded our eco-filtration material. Here we're replacing fossil-based phenolic resins with lignin. That's a byproduct from our industry, and it's in demanding applications for clean air and clean water. If we look at the personalized healthcare, we launched into a new segment for gowns, and I have to say I was particularly proud about this application. It's our ChemoGuard, which addresses what's always been an industry trade-off between high barrier protection for viral barrier coatings with the comfort of the actual gown. Our IP pending technology actually combines complete viral barrier coating against these aggressive drugs, but with our already breathable, lightweight materials, so actually not requiring the compromise. A really, I think, a great new segment that shows the combination of our capabilities. If you have a look at the far right-hand side, our MaxLiner. This is, again, from our Transparency platform. It's a highly transparent release paper, and here it allows accelerated conversion speeds, but it's also got a high level of recycled fiber content. Again, really addressing a couple of different sustainability needs. And I think across the board, what you see here is that as a company, we're constantly challenging what the boundaries of performance are, but with sustainable solutions. Of course, we're also driving that growth momentum quarter after quarter in the company. Let's go deeper into what was also behind the momentum in Q2, and I'd love to hand it over to you, Niklas. Thank you, Helen. Welcome also from my side to today's second quarter call. Helen mentioned, we had a strong Q2, and we delivered accelerated performance. How does this look like in facts and figures? I would like to show you on the next slides. Let's start with slide seven, the top line as always, and I have here basically four messages I would like to convey. First message, reported sales were up 5.6% at reported currency. Growth mainly coming from the acquisitions, of course, also from our portfolio mix improvements, also from good momentum in the market and our discipline pricing. Second message, at constant currencies, the net sales grew even by 7%, almost year-over-year. We still had a slight FX headwind still. Third message, our net sales at constant currencies have grown over the last four quarters right now, and we see continued pickup in the markets also going forward. Fourth message, on this page, the LTM Q2 2026 sales grew to EUR 2.97 billion of sales, so to say. Also there, clear growth trajectory here when it comes to the sales number and top line. If you look now on the right side of this page, how are these sales composed of when it comes to our segments? First message, 82% of our sales were generated in our three core divisions, Filtration & Life Sciences, Food & Consumer Packaging, as well as Protective Materials. Last year, Q2 was still 78%, so we see there a clear growth, which of course is also driven by the Stevens Point acquisition. As you see, Food & Consumer Packaging has grown five percentage points from 25% to 30%. Filtration & Life Sciences, same levels, 36%. Also, Protective Materials are somehow on the same level. Of course, a little bit lower Performance Materials Cluster, also due to the fact that we divested the abrasive business in Q4 2025. Now let's look at the next slide eight, how the top line translate into profitability. Also here, a few messages. First message, comparable EBITDA increased by 16%, reflecting higher profitability basically in all core divisions, and I come back to this in a moment. Secondly, comparable EBITDA increased to EUR 142 million, EUR 19 million higher than Q2 2025, which is a record second quarter, as I had already mentioned. Thirdly, also the EBITDA margin improved by 1.6 percentage points from 16.5% to 18.1% in the second quarter. Also there, the strongest Q2 margin on record, basically demonstrating again our strong portfolio mix pricing power, procurement savings, as well as operational excellence. I will come back to these measures. Fourth message, LTM, also there, let's say on the LTM EBITDA Q2 2026 versus Q1 2026 increase from EUR 484 million to EUR 504 million. Also margin wise, 16.5%-17%. Also here, let's say continued growth. For the core divisions, and I will elaborate this in more details, our comparable EBITDA margin increased from 18.2%-20.6%, as already mentioned also by him. Let's look on the next page at the main profitability driver, which is the Margin On Variable Cost per ton. You see on the right side here the development over the quarters as we show this here, basically in all investor calls. Our MOVC per ton, basically, developed or increased from EUR 1,116 in Q2 last year to EUR 1,145 per ton in the second quarter of 2026. This is even with a negative FX impact. If we take really like for like at constant currencies, the MOVC per ton would be EUR 1,160 per ton. Also there, basically the strongest MOVC per ton, so to say, we have seen here in our company. This is, of course, an effect, as you see on the left side, of the three main drivers. For one, clear, the shift towards higher value specialty products in all segments. Of course, this mix change has been also supported specifically when it comes to the two divisions of Filtration & Life Sciences and Food & Consumer Packaging by the recent acquisitions of Stevens Point and EBF. Second big driver, of course, is the pricing power. We are leveraging here our leading market positions and quality over price specialty products. This, of course, puts us into the position, basically, to pass through inflation. This being also, for example, right now in the first half of the year due to the Middle East crisis, of course. We're able to pass through the inflation basically to our customers. As you see also, 25%-30% of our contracts are indexed. There's always a one to two quarter lag. The remainder is commercially negotiable, which brings it to a good position, as said, that we can pass through any inflation, in deflationary times, even keeping the pricing on a higher level. Last but not least, the transformation initiatives as the third driver, of course, behind our MOVC growth. Here specifically to mention, of course, the United Procurement Saving programs, which is a well-oiled machine, coming up with initiatives on continuous basis, which then are being implemented and generating savings. As well as also in terms of operational excellence, where we have continuous saving program. Recipe 2.0 is a specific tool we have implemented where we basically do data-driven optimization of the input mix to really identify the most cost-effective material input into our products, basically. That's also one big driving tool of our continuous savings we're generating here. Last but not least, of course, also the global footprint consolidation is part of generating here also additional proceeds. Last but not least, to mention, of course, with our operational excellence, of course, we are on a continuous basis also improving our efficiencies. Of course, the more volume we get then also basically into our factories, the better, of course, here also MOVC develops. Yeah, with this, I would like to go to the next page 10, so to say, and look like how the different segments have developed Q2 last year to Q2 this year. Let's start with, of course, the group performance basically has improved during the quarter in general. The core divisions, you see this here very nicely, have increased its EBITDA by 20%, so to say, from EUR 108 million to EUR 135 million. That's a big jump there. Of course, also if we adjust this for the portfolio changes we have done with the Stevens Point acquisition, EBF acquisitions, those two basically in the core divisions. If we adjust this for it and look at like- for- like also constant currencies, we grew comparable EBITDA by EUR 14 million from EUR 100 million to EUR 114 million. It's also there, I think a clear nice profitable growth we are showing there. The margin development, of course, going from 18.2% to 20.6%, 2.4 percentage points, very strong upward trend in our core divisions. If you look at it individually into the respective segments, Filtration & Life Sciences, making up for 38% of our EBITDA with 26% of sales. Here, the margin has increased by 2.6 percentage points, from 23.3% to 25.9%. Mission-critical products, sort of thing, with strong pricing power there, and we are showing their continuous growth. If we look at second, let's say, core division, Food & Consumer Packaging, making up for 30% of our EBITDA, with 31% of our sales. We see here also a clear jump of 1.8 percentage points. Of course, also including, let's say, the acquisition of Stevens Point supporting here, but also stronger volume momentum, as Helen already mentioned, and also strong pricing power. Here, 1.8 percentage points higher EBITDA margin, 17.6%-19.4% in Q2 this year. Last but not least, third core division, Protective Materials. There, very positive development coming basically year-over-year in terms of EBITDA margin. 2.5 percentage points increasing 13.9% right now in last year's quarter two, right now to 16.4%, which is, of course, also driven by really all the one-time operational issues we have resolved in Q1 of this year. We still show the 14.8% margin. Right now, as said here, as shown, 16.4%. Clearly, these one-time operational issues are resolved, and we are growing there also in terms of, let's say, top line. Therefore, here also good growth momentum. Last but not least, our, let's say, Performance Materials Cluster. It looks still year-over-year, making up for 5% of our EBITDA, 18% of sales, of course, significantly lower margin, as we also described and discussed over the last investor calls already. Quarter-over-quarter, slightly below last year. However, if you look at it sequentially, we clearly see that Q1 was still at 3.9% EBITDA margin. Right now, we landed in Q2 at 6.0% with a still solid and stable release liner business. Plus, of course, really also a significant improvement on the beverage and casing side. With this, I would like to look into the quarter-over-quarter bridges when it comes to the different P&L lines, and here top line and EBITDA comparable and reported. We start with the net sales bridge last year to this year, EUR 745 million growing to EUR 786 million with a 6% roundabout growth. At constant currencies almost 7%, as mentioned. The positive elements here in this, what contributed to this growth, of course, to begin with, is the price and mix with EUR 23 million, so strong pricing discipline, as already mentioned. Of course, our volumes also increased slightly, as you see here. M&A with Stevens Point and EBF, of course, contributed. That's another EUR 25 million here. This overcompensated, of course, significantly the slight FX headwinds we still had, which is the EUR 7 million downturn we see also in the sales bridge here. Overall, clear growth momentum we see here. This, of course, is also translating into the comparable EBITDA bridge. We see a clear upward trend, EUR 123 million to EUR 142 million, so EUR 19 million increase and margin-wise, 16.5%-18.1%. What are the main driver behind it? MOVC, marginal variable cost. So to say, we have seen this on the previous page already. Improved here the EBITDA alone by 19%. Of course, again, improved portfolio mix, strong pricing discipline, as well as the procurement and operational excellence saving engine. Of course, on top of this, so to say, we had still the acquisition of Stevens Point and EBF contributing here to the higher EBITDA of EUR 10 million. Volume also slightly positive impact here on this bridge. Of course, overcompensating the negative elements in terms of course, some increased personal costs due to inflation and still some slight FX headwinds. We see the same development, nice and even a little bit more on the group reported EBITDA side. Besides the increase of the EUR 90 million we just have seen on the comparable EBITDA side, on the reported EBITDA, we also see that the change in IAC, in Items Affecting Comparability, are slightly lower than last year. Last year we had EUR 14 million. We have now EUR 12 million in this year. Therefore, a positive impact also here. Overall, the reported EBITDA grew by EUR 21 million or 20%, up to EUR 128 million for the quarter two. Let's have a look also how it has developed sequentially coming from Q1 2026 to Q2 2026. We see this on this page here. The comparable EBITDA increased to 18.1%, basically two percentage points or EUR 23 million. Main drivers here on this side is, to begin with, the volume. You saw the volume sales growth, so to say, here from EUR 738 million to EUR 786 million from Q1 to Q2. Across the core divisions increase, as already also mentioned. However, here when we look Q1 to Q2, Filtration & Life Sciences with a 4.3% increase, Food & Consumer Packaging, 1.5% increase, and Protective Materials, even 6% increase in terms of volume here. The second driver is improved MOVC contributing, of course, another strong EUR 24 million here with all the drivers we have talked about already. Last but not least, these two elements overcompensating some higher personal cost and some negative still, IAC impact also here, so to say. Overall, also very strong growth momentum being shown here in these figures. With this, of course, I would like to always look also a little bit ahead, a little bit the view going forward, by really doing a reconciliation between reported EBITDA and pro forma adjusted EBITDA, always last 12-month view here, LTM. We start, of course, within the first step with the reported EBITDA, adding there the IAC. Second step, we're adding the savings initiatives, which are initiatives which have been defined, so to say, which are in implementation over the next two and a half years, if you want to say, including also our announced strategic improvement initiatives. Third step, we are adjusting them for pre-acquisition comparable EBITDA. If we go briefly through this, in Q2 you see between reported EBITDA and comparable EBITDA, we are adding, of course, the transaction costs, which were more or less due to the M&A transactions we did with the acquisitions, the refinancing, the minority squeeze out. Of course, we're adding the restructuring and other legal costs. You remember last quarter, we booked around about almost EUR 50 million in terms of restructuring cost for basically all the, let's say, strategic improvement measures, including the closure of Radcliffe as well as the right sizing of Mosinee. This overall, plus the management fees, amounts to EUR 118 million last 12-month IACs, bringing the comparable EBITDA of EUR 504 million at 17%. Adding the, let's say, initiatives, as already mentioned, we have out of let's say these initiatives here you see is EUR 96 million roundabout, which are contributing over the next two and a half years. EUR 57 million coming from procurement and operational excellence from our well-oiled machine on generating savings on a continuous basis with a great track record over the last, let's say, years already. On top comes the Stevens Point synergies, additional EUR 7 million in the second half of this year. On top come the, let's say, strategic improvement initiatives mentioned already, Mosinee, with a complete yearly run rate of EUR 11 million, plus the Radcliffe closure complete run rate for a year is EUR 4 million. We will see those, let's say, run rates first time there, EUR 27 million for the complete year. For this year, of course, we have a portion of it in there. As you know, Rectiv has been closed by the end of the first quarter, as a plant and Mosinee rightsizing in terms of paper mill closure and one of the two lines we want to close have been closed right now by the end of the second quarter. The second line will follow basically at the end of the third quarter. On top of last but not least, also as a strategic improvement initiatives here to add is the RWA, our waste reduction program, our global waste reduction program, generating to 2028 also yearly run rate of EUR 18 million. Those elements, procurement operation excellence EUR 57 million, Stevens Point synergies, Mosinee and Rectiv, let's say, rightsizing as well as waste reduction adding up to EUR 96 million, bringing the adjusted EBITDA to EUR 600 million. Which is also equaling the pro forma adjusted EBITDA since the only thing left right now going forward or the only one left going forward is the divestment of abrasives is here being adjusted. The rest is fully in there, so to say. We are ending up with a pro forma adjusted EBITDA margin also of 20.3%. With this, so to say, I would like to, let's now have a look into cash on the next pages. As always, we're starting with the cash from operational performance, let's say it this way. You see on the right side, we are showing stable cash flow from operating activities, EUR 53 million generated in Q2 2026, same level as in the first quarter, double what we have done in last year's quarter two, which was of course also burdened by some transaction costs in relation to our Stevens Point acquisition. If you look at the left side and look through the indirect cash flow bridge and develop it step by step, starting with comparable EBITDA, the IACs Items Affecting Comparability at a normalized level of EUR 14 million. The change in working capital is slightly negative due to the business increase, the business growth we have seen in Q2. Of course our interest and tax payments, et cetera, arriving at a net cash from operating activities for EUR 53 million. CapEx flat year-over-year, so to say, on the same level as last year. We see also on the next page. Positive, let's say, on the M&A and other line here because we were basically divesting our 25% share in. We still had it on our balance sheet together with also getting the payment for the long-term loan basically, we have given them. That's adding up here to another +EUR 60 million. Of course we had some, again, some outflows basically due to repayments of borrowings, some lease liabilities and some dividends. Overall, a net change in cash of +EUR 4 million for the second quarter. If we now look into the little bit more details how CapEx and also net working capital look like, we see on the next page. As mentioned, on the CapEx side, majorly maintenance CapEx here driven EUR 29 million. It's also a little bit seasonality always in the CapEx side. Second quarter is usually the lowest quarter, if you want to say. You see this year also it's in line with last year, very much under control and disciplined spending we have here on our CapEx side. When it comes to group working capital, we clearly see here, of course, some uptick specifically in the receivable side due to the additional growth on the top line. EUR 659, you clearly see here on the operating payables, not increased in the same way due to also lower pulp prices if you compare Q2 last year to Q2 2026. Inventories, in line with our inventory or with our working capital reduction program, has decreased by EUR 40 million, helping us here basically also to further improve our cash conversion cycle, which is anyway, so to say, very stable and on a very, let's say, good basis. With this, I would like to switch over to our liquidity and cash and leverage on the last two pages of my presentation part here, starting with our debt structure. There were two actions ongoing here, basically two achievements in Q2. The one achievement was that we financed our still outstanding US dollar term loan, which was maturing in 2028, of $519 million. We were refinancing this with a new US dollar term loan with a slight markup also of $26 million, which we used for a portion already for all the refinancing costs. This additional $545 million is now part of our debt, which matures in 2030. As you see here, as I already mentioned, we have right now refinanced roundabout 80% of our debt, which is now maturing in 2030. What is left are the senior U.S. dollar and senior euro notes, the bonds, if you want to say, which are still maturing in 2028, we have enough time for taking care of this. So to say, we will address this when it's the right timing for us. We have adequate and competitive conditions also around those, there's no rush into refinancing those. The second big achievement in Q2 was, of course, the extension of our revolving credit facility, which is now maturing with EUR 362 million in 2029. Overall, at the moment, we have EUR 390 million. Also, this ensuring excess of cash basically in all circumstances. I think on the availability community side also, a very comfortable position we are in as Ahlstrom right now for the next steps also in terms of growing the business. Last but not least, last page, looking into the leverage on Slide 17, has not changed, 4.4 as last quarter, slightly lower on the net debt size. You have seen the adjusted EBITDA on the same level, EUR 600 million. Overall, of course, looking at this, our main focus is deleveraging, therefore we are really working on a daily basis on improving our EBITDA to begin with. Of course, also, you have seen the strict cost and CapEx discipline in our numbers. Also, our working capital ratios are improving, as you have seen in the second quarter, specifically also on inventory side. All of this is in motion. Therefore, I think just to summarize, really a record high EBITDA and also EBITDA margin number for Q2, showing that we are here on a good path, basically also to achieve our goals in 2026. With this, I would like to hand back to Helen for the conclusions. Thank you. Thank you, Niklas. Let me just wrap up with some repeats. In terms of key messages, we saw accelerated performance in the quarter. This was, as we've said, and as you can see, based on two things. One, it was the commercial momentum driven by our execution on our opportunity pipeline and the successful integration of our Stevens Point and EBF acquisitions, in combination with the strategic improvement initiatives which we're executing on, and they're all on track, resulting in a really strong increase in our comparable EBITDA. I also do want to mention, because it's still an ongoing situation, we see and have seen limited impact of the Middle East. Then finally, as Niklas has just concluded, we've done the successful refinancing of the U.S. dollar term loan and our RCF, so in a strong, comfortable position. Actually, in my own words, an outstanding performance in Q2. I have to say, I'm incredibly proud of the team and the execution of what we're driving. With that, love to open it up to the floor operator for questions. If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Vihren Jordanov from Polus Capital Management. Please go ahead. Hello. Good afternoon. Congratulations on the good quarter. I was wondering whether you are affected in any way by the large fires, either directly or through some of your end customers, that are currently ongoing in continental Europe. Let me answer that. In terms of the actual wildfires itself, in terms of customers or ourselves, we are not located in any of those locations because, of course, it's a terrible situation that we're observing. We are not located in any of the locations affected. So far, also, our customers have reported no exposure from the wildfires in Europe. Okay. Thank you. As a reminder, if you wish to ask a question, please dial pound key five on your telephone keypad. There are no phone questions at this time. I hand the conference back to the speakers for any written questions and closing comments. Okay. Operator, we've got some questions actually online. First of all, could you elaborate on the current demand environment? Let me actually take that one, because I think it also ties in a little bit to, Andrea, your question. Let me answer it first of all. If I take the core business units, and let me start with the Filtration & Life Sciences first. What we see in our medical and our life science business is just a really strong momentum. We saw that in Q1, we've seen that in Q2. If we look at the filtration part of that business in our industrial segments, which are our clean air and our clean water applications across the globe, strong top-line revenue growth. On the transportation side of filtration, in China and Europe, demand is good in the second quarter. In the U.S., it's been relatively flat at a relatively low-ish level. We've had that situation for a number of quarters. What I said coming out of Q1 was that we were starting to see some of the leading indicators in those segments in the U.S. actually developing positively, and we've seen that continue in Q2. I would say the last few weeks we've seen a little bit more positive momentum also in the U.S. in transportation filtration. That's the one area in that group. Overall, good momentum. If we take the Food & Consumer Packaging, I was a little bit nervous coming out of Q1 talking about it, but did mention that we were seeing increased volume in the pipeline for non-fossil based materials. Our actual inquiry pipeline picked up across the board in our global food segment, and that did materialize in Q2, and the momentum still looks good as we think about Q3. Protective Materials. Two dynamics in Protective Materials. This is the segment where we had some of our one-off operational issues, which we resolved in Q1. We've seen the uptick in volume in the second quarter, and we expect that, of course, to continue because those are resolved. However, the second message here is that is the segment that is most connected to the building and construction sector. There's a portion of it, some of our tape, some of our glass fiber tissue that's in building and construction, and we still see that muted. We don't see yet any improvement in the trajectory. However, we're getting a few rumblings that the European market is starting to uptick a little bit, but that piece of our exposure is still slow. If we look at our release liner business, actually it's tracking according to our expectations. It's solid, but that is below prior year if we talk. We don't ever talk about volume, but if we just look at the overall momentum in release liners, it's solid, it's according to expectations. Pretty stable. I think when it comes to, we don't measure the volume growth, so to say. That's not really reflecting, let's say, our growth momentum. We always, let's say, talk about sales growth on the one side, which we mentioned, I think versus last year, 6% of constant currencies, even roundabout 7% even. I also mentioned the growth rates on the sales side for quarter-over-quarter sequentially for the three core divisions, which were very positive. More than 4% of Filtration, almost 2% for Food & Consumer Packaging, and 6% for Protective Materials. Niklas, maybe Andrea's question, the first one. Also on the back of the Mosinee facility closure, could you please let us know how much real estate you own versus how much is leased? Yeah. We can clearly say that we are owning our plant entities completely. By the way, it's not a closure of Mosinee, of the facility, it's just a rightsizing. We are still keeping two lines active in Mosinee. It's our ownership, this plant, but also the other plants where we do have lease contracts are on the office side, so to say. We talk about sales offices and, let's say, other headquarter offices. The target leverage level. Helen, should I just continue with it right away? Yeah. Of course. Yeah. At the moment or by the end of Q2, we have on the factoring non-recourse side, EUR 216 million. It's EUR 20 million stronger than in Q1 due to the fact that we brought also, of course, a stronger Q2 than Q1 in terms of sales and business, but also because we brought some new customers into the factoring program for our acquired companies, like EBF and Stevens Point. That is also increasing. Factoring non-recourse EUR 216, recourse factoring EUR 14. Of course, we are also having our supply chain financing programs, if you want to say, with our suppliers, we have another EUR 160 million round about. Oh, sorry. I was more on the factoring level already. On the target leverage level, we have 4.4. Of course, we are, let's say, targeting to come to below four as the next step, so to say, within the next year. It's a step-by-step process. I mentioned all the actions we have taken in terms of course, operational result to begin with, but then also working capital to bring it further down and very disciplined CapEx spend. Thanks, Niklas. Andrea, there's another question that says, "Can you please comment on the more cyclical sub-segments of your business which are exposed to construction, auto and EV, and talk a little about how they're doing, what percentage of your business they represent?" Hopefully the voiceover that I gave actually talks about the general conditions that we're seeing across each of the segments. I think just a couple of adds here is just to think about our exposure to construction. As I said, that's predominantly in our Protective Materials segment, and I would take probably circa 30%-35% of that segment. It's across different parts of the industry, but you could look at that in terms of the exposure to building and construction. You also mention about auto and EV. Actually, our exposure, what we see across also the transportation segment is we're seeing strong growth still in China in that business. We see strong growth, in Europe. Again, I wouldn't call that cyclical in terms of the exposure that we've got. I think overall, if we look at the portfolio, maybe what's helpful, Andrea, is we say that the overall exposure in terms of end market to building and construction is circa 9%-10%. The last question is, "How do you see volumes develop for the second half of 2026?" Again, I think Niklas talked about we don't talk about volume, we don't go into the volumes. But like I said, just a little bit of color. If we think about coming out of Q2 into Q3 and Q4, we continue to see the momentum that we talked about in Q2, both in terms of our innovation pipeline, both in terms of the segments that I've talked about. We still see that building and construction exposure being a muted part of the exposure. What I do want to do the caveat with always is the shocks in the system that keep going through in terms of we still face the situation in the Middle East. You know what, we're always cautious about also what we say about the development. I have to say, coming out of Q2 and looking at where we're headed for Q3, we continue. We haven't got any more questions, let me wrap up by thanking you all for attending the call. It's the Q2 one, either wishing you a nice vacation if you're going on vacation or hope you've enjoyed your vacation. Have a good one, look forward to speaking to you with our next quarter Q3 results. Thanks, everyone. Thank you